ArticleTranslational psychiatry2026
Stage-Dependent mediation of white matter hyperintensities between plasma biomarkers and cognitive function in Alzheimer's disease.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
White matter hyperintensities (WMHs) are common in Alzheimer's disease (AD) and may contribute to cognitive impairment. However, the associations between regional WMH volumes, cognitive domains, and plasma biomarkers remain unclear. This study aimed to explore these relationships across the AD spectrum. A total of 311 participants were enrolled, including healthy controls (HC), individuals with subjective cognitive decline (SCD), mild cognitive impairment (MCI), and AD. All participants underwent comprehensive neuropsychological assessment, brain magnetic resonance imaging, and plasma biomarker analysis. WMH volumes were segmented using United Imaging software and classified based on anatomical location: juxtaventricular WMH (juxWMH), periventricular WMH (pWMH), juxtacortical WMH (jcWMH), and deep WMH (dWMH). Correlations among regional WMH volumes, plasma biomarkers, and cognitive domains were analyzed with multiple comparisons. Path analysis was used to assess potential mediation effects. Mediation analyses using bootstrapping were conducted separately in cognitively unimpaired and cognitively impaired groups to assess WMH-mediated pathways between biomarkers and cognition. Compared with HC, SCD, and MCI groups, the AD group showed significantly increased log-transformed (lg) juxWMH volumes (all P < 0.05, Bonferroni corrected). The AD group showed significantly larger lgpWMH and lgjcWMH volumes than HC, SCD and AD groups (all P < 0.05). Lower plasma Aβ42/Aβ40 ratio was associated with higher lgjuxWMH, lgpWMH, and lgjcWMH volumes. Higher lgjuxWMH volume was associated with worse memory (r = -0.16, P = 0.006), language (r = -0.34, P < 0.001), and executive function (r = 0.18, P = 0.003). Similar trends were found for lgpWMH and lgjcWMH volumes. Mediation analysis revealed that in cognitively unimpaired individuals, juxWMH and pWMH primarily mediated amyloid-cognitive associations, while in cognitively impaired patients, mediation expanded to include neuroinflammatory and neurodegeneration pathways across multiple location-specific WMH. Location-specific WMH demonstrate stage-dependent mediation patterns in AD pathophysiology, evolving from amyloid-driven changes to multi-factorial processes. These findings provide insights for developing targeted therapeutic strategies at different disease stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.